Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Borsetti

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Antibiotics and Chemotherapy|January 1, 1996
Vaccination of cynomolgus monkeys with whole inactivated or live-attenuated simian immunodeficiency virusF Titti, L Sernicola, F Corrias, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2009
Primary effusion lymphoma cells undergoing human herpesvirus type 8 productive infection produce C-type retroviral particlesA Tinari, F Superti, M G Ammendolia, et al.
Journal of Virology|January 28, 1998
Use of murine CXCR-4 as a second receptor by some T-cell-tropic human immunodeficiency virusesC Parolin, A Borsetti, H Choe, et al.
Nature|November 14, 1996
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5L Wu, N P Gerard, R Wyatt, et al.
Tissue Antigens|April 13, 2012
Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cyA Borsetti, M T Maggiorella, L Sernicola, et al.
Clinical and Experimental Immunology|March 6, 2002
Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytesR Zamarchi, P Allavena, A Borsetti, et al.
Archives of Virology|December 18, 2007
Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeysA Borsetti, S Baroncelli, M T Maggiorella, et al.
The Journal of General Virology|February 12, 1998
Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeysF Titti, L Sernicola, A Geraci, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Antibiotics and Chemotherapy|January 1, 1996
Vaccination of cynomolgus monkeys with whole inactivated or live-attenuated simian immunodeficiency virusF Titti, L Sernicola, F Corrias, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2009
Primary effusion lymphoma cells undergoing human herpesvirus type 8 productive infection produce C-type retroviral particlesA Tinari, F Superti, M G Ammendolia, et al.
Journal of Virology|January 28, 1998
Use of murine CXCR-4 as a second receptor by some T-cell-tropic human immunodeficiency virusesC Parolin, A Borsetti, H Choe, et al.
Nature|November 14, 1996
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5L Wu, N P Gerard, R Wyatt, et al.
Tissue Antigens|April 13, 2012
Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cyA Borsetti, M T Maggiorella, L Sernicola, et al.
Clinical and Experimental Immunology|March 6, 2002
Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytesR Zamarchi, P Allavena, A Borsetti, et al.
Archives of Virology|December 18, 2007
Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeysA Borsetti, S Baroncelli, M T Maggiorella, et al.
The Journal of General Virology|February 12, 1998
Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeysF Titti, L Sernicola, A Geraci, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Pageof 3